GlassScriptPhysician profile
David C Metz
NPI 1225042252
$66,338.76
in general payments reported to CMS, 2019-2025
10 companies · $9,868 in 2025
The $9,868 reported for 2025 was more than what 93% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $14K · 2021: $4,600 · 2022: $14.72 · 2023: $14K · 2024: $6,875 · 2025: $9,868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,043.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $24,237.40 | 2020-2023 | |
| E.R. Squibb & Sons, L.L.C. | $16,743.33 | 2024-2025 | |
| Covidien LP | $6,430.00 | 2019 | |
| Curium US LLC | $5,885.85 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $4,640.60 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $3,600.00 | 2021 | |
| Advanced Accelerator Applications | $2,786.86 | 2019 | |
| Sun Pharmaceutical Industries INC. | $1,000.00 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $1,000.00 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.72 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Metz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.